The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to McGuire et al., N Engl J Med 334(1):1-6 January 4, 1996.

Correction
PreviousPrevious
Volume 334:1070 April 18, 1996 Number 16
NextNext

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by McGuire, W. P.
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer . On page 1, in the Results paragraph of the Abstract, the fourth sentence should have read, "Among 216 women with measurable disease, 51 percent of the cisplatin–paclitaxel group had a complete response to therapy and 22 percent a partial response, whereas 31 percent of the cisplatin–cyclophosphamide group had a complete response and 29 percent a partial response (P = 0.01, {xi}22 = 8.97)."



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.